Safety Study of the Rapid System for Acute Ischemic Stroke
Phase 1
Completed
- Conditions
- Acute Ischemic Stroke
- Interventions
- Device: Rapid System
- Registration Number
- NCT01404403
- Lead Sponsor
- Rapid Medical
- Brief Summary
This is a safety study of the Rapid System for acute ischemic stroke.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Patients ≥18 to <85 years old
- Pre stroke modified Rankin Scale (mRS) of ≤2
- A signed informed consent by patient or a legally acceptable representative
Exclusion Criteria
- Pre-stroke life expectancy of less than 6 months
- Current participation in another investigational drug or device study
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Stroke patients Rapid System -
- Primary Outcome Measures
Name Time Method Percentage of participants with Adverse Device Effects (ADEs) Percentage of participants with Adverse Device Effects (ADEs)Percentage 12 patients
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Karolinska Hospital
🇸🇪Stockholm, Solna, Sweden